Therefore, the aim of this study was to perform a comprehensive study of PD-L1 as a biomarker in breast cancer using automated tumour recognition and quantitative IHC image analysis together with objective scoring systems on uniform patient tissue cohorts with extensive clinical annotation. This evidence concerns the gene CD274 and neoplasm.